Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
4,901	74.836	1	female	0	55	205	Coma	Coma	2	12	$11-$25k	44	121,446	73,198.25	74,076	22.75	white	27.898438	42	0.231995	0.166992	3	0	0	no	0.5	0.4	no dnr	55	78	13.798828	105	16	36	145	null	null	0.899902	135	7.449219	96	31	3,745	null	0	adl>=4 (>=5 if sur)	0
4,902	67.29895	1	male	0	16	145	Lung Cancer	Cancer	1	12	under $11k	0	16,352	11,122.2734	12,129	9	white	21.597656	14	0.5979	0.279968	1	0	0	metastatic	0.6	0.2	dnr after sadm	13	67	9.898438	105	16	36.09375	null	null	0.899902	0.899902	135	null	87	12	1,650	0	0	no(M2 and SIP pres)	0
4,903	65.03796	0	female	0	40	772	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	>$50k	0	102,799	63,792.2188	61,464	26.25	white	26.199219	44	0.772949	0.699951	1	0	0	no	0.5	0.5	no dnr	40	105	2.599609	130	8	38.19531	260	1.199951	null	1.199951	136	7.399414	104	15	1,373	null	6	no(M2 and SIP pres)	6
4,904	55.05499	1	male	1	6	6	MOSF w/Malig	ARF/MOSF	1	24	>$50k	0	44,118	26,434.5938	25,920	31	white	40	73	0.107986	0.045998	18	0	0	metastatic	0.1	0	dnr after sadm	2	72	10.398438	101	16	36.5	null	3.799805	0.899902	1.199951	133	null	265	18	1,775	null	null	<2 mo. follow-up	2.449219
4,905	28.19399	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	11	null	0	96,558	57,177.4688	61,408	38	white	46.296875	74	0.416992	0.297974	13	0	0	no	0.1	0.05	dnr after sadm	2	62	6.399414	60	10	36.09375	170	null	null	0.599976	139	7.419922	115	10	3,025	null	1	<2 mo. follow-up	1
4,906	60.66299	1	male	1	33	33	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	9	188,767	103,457.812	109,782	35.75	white	50.398438	58	0.112991	0.048996	3	0	0	no	0.8	0.7	dnr after sadm	33	52	21	145	10	39.29688	182.21875	1.899902	2.899902	1.5	139	7.5	196	55	330	null	null	<2 mo. follow-up	1.978027
4,907	55.56198	0	female	0	16	770	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	35,993	20,256.8438	21,664	22.666656	white	26.5	31	0.802979	0.737915	1	0	0	no	0.8	0.7	no dnr	16	73	8.898438	115	24	35.59375	623.75	2	6.199219	1	128	7.469727	91	6	750	null	2	SIP>=30	2
4,908	75.28796	1	female	1	5	5	Coma	Coma	2	14	under $11k	61	null	11,422.7578	14,040	34	white	41.59375	72	0.006	0.002	1	0	0	no	0.15	0.1	dnr after sadm	2	98	5	70	20	36.29688	null	2.899902	0.399963	1.099854	141	null	158	5	9,000	null	1	<2 mo. follow-up	1
4,909	75.27698	0	female	0	53	769	COPD	COPD/CHF/Cirrhosis	3	null	>$50k	37	129,050	77,979.6875	77,337	26.25	white	20.597656	29	0.689941	0.523926	1	0	0	no	0.5	0.5	no dnr	53	75	23.398438	115	35	38.5	211.40625	2.199707	0.799927	1.099854	138	7.429688	174	13	1,860	null	0	no(M2 and SIP pres)	0
4,910	53.02698	1	male	0	5	385	CHF	COPD/CHF/Cirrhosis	5	8	under $11k	0	3,519	2,716.1777	2,575	2	black	14.199219	24	0.930908	0.882935	1	1	0	no	null	null	no dnr	5	83	7.799805	55	12	35.39844	512	2	3.799805	3.299805	134	7.40918	141	97	1,900	0	null	no(M2 and SIP pres)	0.494751
4,911	65.44299	1	male	0	14	105	Lung Cancer	Cancer	2	19	null	0	15,948	10,670.1875	12,667	7.333332	white	18.898438	21	0.666992	0.366943	1	0	0	metastatic	0.7	0.3	no dnr	14	108	15.298828	125	38	37.59375	252	null	0.799927	0.699951	136	7.349609	136	9	665	null	5	null	5
4,912	54.543	1	male	0	10	192	Lung Cancer	Cancer	1	5	$25-$50k	0	17,099	10,467.5703	10,611	11	white	4.699219	2	0.891968	0.75293	1	0	0	metastatic	1	0.5	no dnr	10	112	25.796875	100	12	36.39844	348	1.599854	0.399963	0.5	138	7.429688	144	10	990	0	0	no(M2 and SIP pres)	0
4,913	80.28198	1	male	1	5	5	Lung Cancer	Cancer	2	null	null	26	9,725	null	null	20	black	30.199219	43	0.182983	0.014999	1	0	0	metastatic	null	null	dnr after sadm	3	93	8	65	20	36.19531	null	null	0.5	0.899902	138	null	199	15	2,400	null	6	<2 mo. follow-up	6
4,914	52.88199	1	female	0	11	504	Cirrhosis	COPD/CHF/Cirrhosis	1	17	null	0	30,125	19,121	19,548	12.5	white	22	34	0.748901	0.60498	8	0	0	no	null	null	no dnr	11	48	15.298828	105	60	37.89844	295	null	0.699951	1.5	134	7.379883	203	27	2,200	1	1	null	1
4,915	60.65399	1	male	0	21	67	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	0	71,922	39,465	42,149	29	white	29.199219	44	0.721924	0.636963	2	0	0	no	0.55	0.5	no dnr	21	42	1.299805	75	12	35.69531	230	2.5	22.296875	2.199707	146	7.339844	157	84	340	0	0	no(M2 and SIP pres)	0
4,916	55.181	1	male	0	7	288	Lung Cancer	Cancer	1	12	$25-$50k	0	4,957	3,451.5	3,383	3.5	white	13.798828	9	0.785889	0.549927	1	0	0	metastatic	0.6	0.25	no dnr	7	118	14	125	10	36.69531	260.6875	4.099609	null	0.699951	140	7.369141	119	11	2,670	2	0	SIP>=30	0
4,917	50.01199	0	male	0	3	764	Lung Cancer	Cancer	1	20	>$50k	0	6,388	3,168.7422	1,350	11	white	12	6	0.81897	0.609985	1	0	0	metastatic	1	0.8	no dnr	3	65	9.298828	120	10	36.29688	177.75	1.5	4.199219	3.199707	146	7.389648	214	85	2,815	null	null	no(M2 and SIP pres)	1.865723
4,918	22.62799	0	male	0	37	763	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	$25-$50k	0	323,059	189,009.25	197,291	40	black	29.097656	51	0.826904	0.767944	10	0	0	no	null	null	no dnr	37	72	6.099609	60	20	36.5	null	null	null	2.099609	139	null	83	53	1,300	null	4	no(M2 and SIP pres)	4
4,919	47.62799	1	male	0	76	521	MOSF w/Malig	ARF/MOSF	1	12	null	0	376,664	207,720	198,047	45.25	white	30.699219	56	0.399963	0.280945	7	0	0	metastatic	null	null	no dnr	76	70	23.296875	64	28	37.79688	null	2.5	11.898438	0.599976	131	null	33	4	null	null	0	adl>=4 (>=5 if sur)	0
4,920	73.59094	0	female	0	25	762	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	73,327	43,064.3438	48,526	27.25	white	22.097656	28	0.804932	0.740967	1	1	0	no	0.6	0.4	no dnr	25	127	0.399963	115	33	36.69531	428.5625	2.899902	22.398438	8.599609	154	7.30957	195	142	2,130	null	0	no(M2 and SIP pres)	0
4,921	36.76099	0	female	0	14	761	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	41,480	24,610.7969	23,436	29.333328	black	26.097656	33	0.863892	0.815918	1	0	0	no	0.7	0.7	no dnr	14	72	14.599609	110	32	38.09375	200	2.099609	0.699951	0.699951	143	7.449219	206	10	3,200	null	0	no(M2 and SIP pres)	0
4,922	82.75696	1	male	0	29	279	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	$11-$25k	0	73,813	44,928.0625	47,449	20.5	white	17.199219	17	0.797974	0.731934	8	0	1	no	0.8	0.8	no dnr	29	72	6.5	45	16	36	null	null	null	1.799805	138	null	188	57	2,550	null	null	no(M2 and SIP pres)	4.93457
4,923	70.21997	0	female	0	10	761	Colon Cancer	Cancer	1	12	null	0	16,592	9,469.4141	6,130	9.5	white	14.898438	5	0.833984	0.638916	1	0	0	metastatic	0.8	0.6	no dnr	10	55	15.199219	145	0	36.69531	190	null	null	2.299805	136	7.489258	361	48	2,670	1	0	no(M2 and SIP pres)	0
4,924	77.35498	1	male	0	28	66	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	63,807	38,045.8125	41,215	24.25	white	28.796875	49	0.668945	0.572998	1	0	0	no	null	null	dnr after sadm	11	128	14.898438	110	35	36	98.75	null	1.599854	0.699951	136	7.519531	267	26	1,535	null	2	null	2
4,925	48.40198	1	male	0	5	21	Lung Cancer	Cancer	1	16	$25-$50k	0	4,142	2,687.8477	2,925	7	white	25.296875	26	0.56189	0.23999	1	0	0	metastatic	0.1	0	no dnr	5	135	30.898438	125	18	38	208.5625	null	7.299805	1.199951	141	7.439453	109	35	1,350	0	1	<2 mo. follow-up	1
4,926	38.875	0	female	0	19	760	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	0	113,529	65,544.0625	62,624	16	white	21.199219	16	0.859985	0.81189	42	0	0	no	0.8	0.8	no dnr	19	53	13	55	22	38.79688	191.40625	2.099609	1.599854	7.5	121	7.379883	150	113	88	5	7	adl>=4 (>=5 if sur)	7
4,927	65.93597	1	female	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	15	under $11k	0	62,017	36,789.2188	37,194	36	black	33.195313	80	0.631958	0.529907	1	1	0	no	0.75	0.65	dnr after sadm	9	60	16.398438	125	10	38.19531	133.3125	2.399902	2.399902	1.099854	130	7.489258	97	9	1,970	null	0	<2 mo. follow-up	0
4,928	60.44397	0	female	0	16	759	Coma	Coma	0	12	under $11k	44	44,441	27,747.375	32,373	25	white	20.699219	22	0.581909	0.515991	3	0	0	no	0.6	0.6	dnr after sadm	1	67	19.5	108	20	34.29688	338.0625	null	3.699707	3.299805	147	7.539062	111	78	1,300	null	0	adl>=4 (>=5 if sur)	0
4,929	57.51099	0	male	0	18	759	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	0	76,162	43,470.0625	48,418	27.666656	white	26.199219	36	0.775879	0.703979	3	1	0	no	0.85	0.8	no dnr	18	58	11.798828	155	40	37.89844	130	2.5	6.899414	1.199951	134	7.609375	167	48	2,002	null	0	no(M2 and SIP pres)	0
4,930	58.28098	0	female	0	9	759	COPD	COPD/CHF/Cirrhosis	3	13	null	0	10,409	6,518.168	7,685	10	white	13.798828	14	0.932983	0.885986	1	0	0	no	0.9	0.9	no dnr	9	118	11	55	22	37.79688	272.5	null	null	0.699951	136	7.429688	153	5	5,295	1	2	no(M2 and SIP pres)	2
4,931	62.80899	1	female	1	15	15	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	26	78,898	44,584.9688	44,423	51.666657	white	26.898438	43	0.521973	0.405945	1	0	0	yes	0.5	0.2	dnr after sadm	9	112	17.597656	135	44	38.59375	146.65625	2.599609	0.5	1.699951	149	7.429688	148	23	1,530	null	6	<2 mo. follow-up	6
4,932	51.16498	1	male	0	5	76	Lung Cancer	Cancer	1	15	>$50k	0	6,343	3,586.1406	2,249	10	white	21.398438	9	0.649902	0.343994	1	0	0	metastatic	0.9	0.5	no dnr	5	130	14.5	75	25	38.09375	300	null	0.5	1.5	146	7.449219	384	39	3,890	0	0	no(M2 and SIP pres)	0
4,933	60.52798	0	female	0	11	757	COPD	COPD/CHF/Cirrhosis	1	9	$11-$25k	0	10,831	7,174.082	7,566	10.5	white	19.796875	20	0.883911	0.806885	1	0	0	no	0.9	0.9	no dnr	11	68	14.5	125	12	35.59375	220	null	1.799805	1.5	140	7.429688	177	41	4,000	0	0	no(M2 and SIP pres)	0
4,934	45.56299	0	male	0	13	756	MOSF w/Malig	ARF/MOSF	1	18	under $11k	0	92,440	48,631.625	37,753	40	white	49.59375	88	0.014	0.003	8	0	0	metastatic	0.5	0.5	no dnr	13	50	18.296875	115	20	36.5	72	2.099609	6.299805	5.699219	139	7.339844	100	63	580	null	null	no(M2 and SIP pres)	2.366211
4,935	71.16998	0	female	0	53	756	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	under $11k	0	248,546	142,914.625	144,234	43.75	black	21.199219	32	0.771973	0.697998	12	1	0	no	null	null	no dnr	53	123	16.796875	75	16	36.89844	130	2.399902	null	1.299805	137	7.349609	128	26	2,240	null	1	SIP>=30	1
4,936	76.85999	0	female	0	18	756	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$11-$25k	0	35,513	22,049.8125	23,664	15.333328	white	28	36	0.687988	0.595947	1	0	0	no	0.7	0.5	no dnr	18	125	14.298828	135	12	39	263.3125	3.399902	1.899902	0.699951	138	7.529297	120	11	2,985	3	3	no(M2 and SIP pres)	3
4,937	66.612	1	male	0	9	333	MOSF w/Malig	ARF/MOSF	2	17	$25-$50k	0	15,178	9,082.9531	9,389	15	other	34.796875	71	0.329956	0.214996	1	1	0	metastatic	null	null	no dnr	9	38	15.599609	75	20	36.79688	131.40625	2.099609	3.899902	4.699219	144	7.419922	89	49	120	0	2	adl>=4 (>=5 if sur)	2
4,938	80.23798	0	female	0	27	754	ARF/MOSF w/Sepsis	ARF/MOSF	0	8	null	0	42,852	26,986.3438	25,946	10.75	black	29	24	0.589966	0.480957	5	0	0	no	null	null	no dnr	27	50	5.399414	195	30	39.19531	270	3.199707	0.899902	4.899414	136	7.459961	149	47	460	null	5	adl>=4 (>=5 if sur)	5
4,939	30.245	1	male	1	4	4	Coma	Coma	1	null	null	100	11,320	6,489.4727	6,158	30	black	81.6875	83	0	0	1	0	0	metastatic	null	null	no dnr	4	47	17.296875	125	38	36.69531	116.65625	null	null	1.099854	142	7.299805	273	58	5,450	null	null	<2 mo. follow-up	1.56958
4,940	50.36798	1	female	1	24	24	Coma	Coma	1	18	$11-$25k	0	56,208	34,438.6875	34,426	23	black	35.59375	83	0.357971	0.284973	1	0	0	metastatic	0.15	0.05	no dnr	24	67	19	95	28	36.69531	228.5625	null	null	1.599854	142	7.399414	83	30	null	null	7	<2 mo. follow-up	7
4,941	55.16199	1	female	0	10	66	Lung Cancer	Cancer	1	null	null	0	8,135	5,829.5977	5,938	1.5	white	19	11	0.690918	0.399963	1	0	0	metastatic	0.7	0.4	no dnr	10	57	15.398438	145	38	35.79688	230	null	0.599976	1.399902	142	7.389648	92	44	985	null	null	null	2.23584
4,942	40.271	1	male	0	21	109	CHF	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	58,691	31,759.5156	24,767	29.333328	white	20.199219	13	0.915894	0.85791	1	0	0	no	null	null	dnr after sadm	8	47	17.5	75	32	38.69531	134	1.899902	0.699951	1.099854	132	7.439453	107	18	1,659	0	1	no(M2 and SIP pres)	1
4,943	68.25494	0	male	0	12	752	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	null	0	92,206	50,704.9062	57,568	36	white	25.199219	45	0.714966	0.62793	10	1	0	no	0.8	0.7	no dnr	12	62	9.699219	105	10	38	245.6875	null	null	1.5	134	7.489258	114	38	5,780	0	0	no(M2 and SIP pres)	0
4,944	84.29797	1	female	1	17	17	MOSF w/Malig	ARF/MOSF	0	16	$25-$50k	100	109,768	63,122.5938	61,147	46	white	40.898438	68	0.001	0	2	0	0	yes	null	null	dnr after sadm	17	132	8.599609	120	30	38.5	135	2.599609	null	0.899902	150	7.429688	153	17	3,570	null	3	<2 mo. follow-up	3
4,945	80.474	0	female	0	47	751	ARF/MOSF w/Sepsis	ARF/MOSF	0	18	>$50k	26	204,836	121,360.25	126,090	33.25	white	28.597656	49	0.417969	0.297974	27	0	0	no	null	null	no dnr	47	128	5	52	20	36.69531	null	3.899902	0.699951	1.299805	137	null	81	9	3,200	null	0	adl>=4 (>=5 if sur)	0
4,946	46.89099	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	4	5	under $11k	44	50,893	30,054.4062	29,646	38	white	41.296875	88	0.267944	0.16098	3	0	0	no	0.1	0.1	dnr before sadm	-1	108	11.699219	115	24	38	297.3125	3.099609	0.599976	0.899902	133	7.469727	133	19	2,045	null	0	<2 mo. follow-up	0
4,947	67.90997	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	49,488	29,109.1094	32,586	31	white	66.296875	111	0	0	12	0	0	no	null	null	dnr after sadm	1	66	10.5	70	12	36.29688	200	3.199707	0.599976	0.5	131	7.389648	98	15	3,680	null	null	<2 mo. follow-up	1.515381
4,948	89.07599	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	null	0	63,254	37,061.9688	34,964	35	white	21.597656	55	0.680908	0.586914	14	0	0	no	0.5	0.3	dnr after sadm	1	77	23.398438	70	27	35.19531	266.625	null	0.299988	3.599609	146	7.399414	163	60	4,500	null	1	<2 mo. follow-up	1
4,949	40.20798	1	male	1	4	4	MOSF w/Malig	ARF/MOSF	2	14	null	100	84,543	52,347.1875	54,819	49	black	62.09375	118	0	0	22	0	0	yes	0.15	0.1	no dnr	4	73	4	65	20	38.09375	328.5625	2.799805	0.799927	1.399902	139	7.449219	107	13	null	null	null	<2 mo. follow-up	2.652832
4,950	47.64697	1	female	0	9	400	CHF	COPD/CHF/Cirrhosis	4	8	under $11k	0	42,225	23,947.1406	25,219	21.5	black	26.898438	51	0.796997	0.67395	7	1	0	no	0.7	0.6	no dnr	9	67	19.597656	140	34	38.09375	160	2.599609	0.399963	0.699951	143	7.449219	83	35	1,390	0	0	no(M2 and SIP pres)	0
4,951	59.461	0	female	0	13	747	Colon Cancer	Cancer	1	10	$25-$50k	0	19,294	11,926.1016	11,618	13	white	14.798828	16	0.852905	0.67395	1	0	0	metastatic	0.8	0.75	no dnr	13	52	11.298828	175	26	38.89844	53	null	1	1	131	7.279297	170	19	460	0	1	no(M2 and SIP pres)	1
4,952	64.44598	1	female	0	10	71	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	0	null	null	null	19	black	26.398438	51	0.773926	0.700928	1	1	0	no	null	null	dnr after sadm	5	118	52.09375	115	14	36.09375	104.20312	3.099609	24.597656	3.799805	138	7.479492	186	57	840	null	6	adl>=4 (>=5 if sur)	6
4,953	77.21295	0	male	0	38	748	MOSF w/Malig	ARF/MOSF	2	17	$25-$50k	44	null	103,211.875	96,555	31	white	28.597656	56	0.221985	0.123993	25	0	0	yes	0.8	0.8	no dnr	38	40	6.599609	0	8	37.89844	102	null	null	2.699707	144	7.389648	153	46	2,010	null	0	no(M2 and SIP pres)	0
4,954	47.79999	0	male	0	16	747	ARF/MOSF w/Sepsis	ARF/MOSF	1	5	$11-$25k	9	51,266	30,347.0781	31,147	29.666656	white	36.5	61	0.593994	0.485962	2	1	0	no	null	null	no dnr	16	67	22.5	115	7	35.39844	165	3.199707	0.5	1.099854	139	7.399414	158	26	2,220	null	null	no(M2 and SIP pres)	2.268066
4,955	80.51996	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	9	92,304	53,414	50,942	35.666657	white	22.199219	31	0.531982	0.416992	14	0	0	metastatic	0.6	0.2	dnr after sadm	15	42	19.097656	75	38	39	126.65625	null	1.799805	3.199707	139	7.459961	155	71	375	null	0	<2 mo. follow-up	0
4,956	57.125	1	male	0	8	63	Lung Cancer	Cancer	2	14	$25-$50k	0	19,218	10,343.4609	8,155	11	white	25.5	16	0.529907	0.20697	1	0	0	metastatic	0.8	0.5	no dnr	8	120	7.699219	115	32	38.29688	216.65625	null	1.099854	0.599976	142	7.399414	144	16	1,360	2	2	adl>=4 (>=5 if sur)	2
4,957	41.39398	1	male	0	7	33	Colon Cancer	Cancer	1	13	$11-$25k	0	16,309	9,141.0547	9,664	11.5	white	21.5	12	0.79895	0.572998	1	0	0	metastatic	null	null	dnr after sadm	1	125	8.099609	75	20	36.79688	null	null	null	1.299805	137	null	182	20	1,400	1	0	<2 mo. follow-up	0
4,958	60.95798	1	female	1	14	14	MOSF w/Malig	ARF/MOSF	1	10	under $11k	0	46,783	26,275.0781	29,210	31	black	24.699219	39	0.652954	0.553955	3	0	0	yes	0	0	dnr after sadm	7	103	7.699219	106	20	36.39844	null	null	0.5	1.5	136	null	141	20	null	null	2	<2 mo. follow-up	2
4,959	71.27197	1	male	0	3	357	Colon Cancer	Cancer	2	12	null	0	7,277	4,163.2031	4,064	8	white	15.199219	13	0.828979	0.62793	1	1	0	metastatic	null	null	no dnr	3	97	8.5	86	20	36.89844	null	4.299805	0.599976	0.899902	142	null	133	14	null	0	null	null	0.494751
4,960	42.27499	0	female	0	16	745	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	81,268	48,695.8438	50,227	22.666656	black	31.597656	77	0.710938	0.623901	10	0	0	no	0.95	0.95	no dnr	16	101	11.199219	110	42	35.5	214.8125	3	0.5	1	144	7.299805	87	31	1,700	0	0	SIP>=30	0
4,961	49.37698	0	female	0	37	745	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	$25-$50k	94	null	57,057.7812	63,000	35.5	white	19.296875	37	0.659912	0.56189	1	0	0	no	0.15	0.1	dnr after sadm	15	115	20.398438	71	16	36.29688	null	2.199707	4.399414	0.699951	134	null	97	18	530	null	0	null	0
4,962	63.85199	1	female	0	6	25	Lung Cancer	Cancer	2	7	under $11k	0	7,383	4,555.8555	5,467	9	white	24.296875	23	0.53894	0.21698	1	0	0	metastatic	0.05	0	dnr after sadm	2	68	12.699219	135	6	38.19531	188.3125	null	null	1.799805	131	7.459961	154	41	3,860	null	6	<2 mo. follow-up	6
4,963	73.71399	1	male	0	36	72	ARF/MOSF w/Sepsis	ARF/MOSF	1	17	$11-$25k	41	null	46,177.1562	46,321	30.5	white	35.898438	63	0.299988	0.188995	1	0	0	no	0.1	0.1	no dnr	36	110	4.599609	66	24	38.59375	null	null	1.099854	1.299805	141	null	265	9	null	null	0	null	0
4,964	62.379	1	female	1	111	111	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	>$50k	26	363,297	null	null	40.25	white	46.296875	71	0.163971	0.081985	1	1	0	no	0.8	0.7	no dnr	111	95	5.099609	78	20	36.59375	null	3.599609	0.599976	1.099854	140	null	104	8	5,625	null	0	adl>=4 (>=5 if sur)	0
4,965	65.01294	1	female	1	11	11	Coma	Coma	1	12	null	44	69,652	39,999.1562	36,347	36.5	black	27.5	60	0.291992	0.221985	9	0	0	no	0.5	0.25	dnr after sadm	11	142	6	105	10	35.39844	186.65625	1.899902	3.799805	1.799805	137	7.479492	165	40	4,653	null	0	<2 mo. follow-up	0
4,966	71.49097	1	female	0	46	52	ARF/MOSF w/Sepsis	ARF/MOSF	3	5	under $11k	100	71,954	46,952.9062	45,922	27.25	white	30.5	47	0.178986	0.091995	1	1	0	no	0.5	0.3	dnr after sadm	22	125	18.5	105	13	37.89844	165	1.799805	1.699951	4.799805	146	7.339844	75	59	1,660	null	2	<2 mo. follow-up	2
4,967	55.61398	1	male	0	6	49	Colon Cancer	Cancer	2	12	$25-$50k	0	7,829	null	null	13	white	34.195313	19	0.478943	0.161987	1	0	0	metastatic	0.8	0.5	no dnr	6	73	10.599609	65	24	39.19531	144	null	1.199951	1.299805	135	7.489258	216	28	3,130	3	null	<2 mo. follow-up	2.510742
4,968	77.04297	0	male	0	14	742	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	38,469	22,497.7969	24,782	19.666656	white	31.5	48	0.609985	0.50293	1	0	0	no	0.5	0.47	no dnr	14	65	11	135	45	38	182.84375	null	1.5	1.199951	143	7.40918	97	16	3,390	null	0	no(M2 and SIP pres)	0
4,969	85.03998	1	female	1	14	14	Coma	Coma	1	null	null	44	9,931	null	null	7.333332	black	16.898438	28	0.41095	0.336975	1	0	0	yes	0.1	0.01	dnr after sadm	2	113	7.799805	65	10	38	276.625	null	null	0.699951	129	7.509766	96	15	1,180	null	7	<2 mo. follow-up	7
4,970	60.54498	1	female	1	8	8	COPD	COPD/CHF/Cirrhosis	1	5	under $11k	44	40,885	22,991.3438	23,333	35.5	white	25.199219	25	0.654907	0.477966	4	0	0	no	0.8	0.7	dnr after sadm	8	89	5.699219	60	20	36.5	null	null	0.5	1	140	null	142	16	2,975	null	0	<2 mo. follow-up	0
4,971	65.03796	1	female	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	44	67,810	38,456.7188	35,168	46	black	35.796875	70	0.32196	0.207977	2	0	1	no	0.15	0.1	dnr after sadm	9	68	14.699219	80	10	35.59375	342.5	null	0.599976	5.599609	130	7.40918	129	129	560	null	1	<2 mo. follow-up	1
4,972	63.83298	1	female	1	8	8	Coma	Coma	0	null	null	44	27,301	15,918.8828	13,193	33.5	white	17.398438	18	0.670898	0.613892	1	0	0	no	0.1	0.1	dnr after sadm	4	68	29.597656	75	20	36.39844	null	2.899902	0.5	1.399902	134	null	115	30	null	null	null	<2 mo. follow-up	1.709473
4,973	51.87399	0	male	0	11	728	Cirrhosis	COPD/CHF/Cirrhosis	2	null	null	0	18,135	11,270.7422	11,102	9	white	14.599609	18	0.887939	0.812988	1	0	0	no	null	null	no dnr	11	62	2.099609	72	16	38	536	2.699707	0.5	0.5	138	7.439453	89	8	4,440	null	null	null	2.592773
4,974	18.88799	0	male	0	23	728	Coma	Coma	0	11	$25-$50k	55	61,596	37,417.375	37,582	21.333328	white	22.5	28	0.819946	0.784912	1	0	0	no	0.5	0.6	no dnr	23	112	18.296875	125	44	38.89844	120	2.699707	0.399963	2.099609	145	7.189453	417	45	1,445	null	0	no(M2 and SIP pres)	0
4,975	65.5	1	female	1	6	6	MOSF w/Malig	ARF/MOSF	2	12	under $11k	26	null	46,616.8125	45,603	47	white	37	75	0.121994	0.053993	18	1	0	yes	0.1	0.05	dnr after sadm	6	63	13.5	55	10	36.09375	310	null	2.399902	1	135	7.439453	93	20	2,135	null	1	<2 mo. follow-up	1
4,976	74.08099	1	female	0	10	589	COPD	COPD/CHF/Cirrhosis	2	7	under $11k	0	10,223	6,574.7031	7,437	9.5	white	15.398438	18	0.871948	0.786987	1	0	0	no	0.7	0.6	no dnr	10	62	6.899414	115	36	39.59375	157.5	null	null	0.899902	134	7.489258	424	16	2,145	1	2	no(M2 and SIP pres)	2
4,977	62.14398	1	male	0	10	77	Lung Cancer	Cancer	1	8	$11-$25k	0	12,666	7,809.8164	8,016	16.5	white	17	12	0.713989	0.434998	1	0	0	metastatic	0.8	0.4	no dnr	10	104	10.898438	70	20	36.39844	316	4	0.599976	0.699951	137	7.399414	147	22	2,200	0	0	adl>=4 (>=5 if sur)	0
4,978	73.56897	1	male	1	15	15	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	69,294	36,262	40,435	50.333313	white	25.199219	45	0.759888	0.619995	1	1	0	no	0.6	0.5	dnr after sadm	13	65	2.899902	135	30	39.19531	228.5625	null	0.699951	1.199951	147	7.369141	231	31	3,775	null	2	<2 mo. follow-up	2
4,979	65.08398	1	female	0	49	64	Coma	Coma	1	11	under $11k	9	244,277	142,366.5	146,695	44.5	black	29.097656	49	0.304993	0.234985	26	0	0	yes	0.3	0.3	dnr after sadm	43	77	12.298828	100	20	36.69531	null	3.099609	0.399963	1	142	null	92	16	null	null	1	adl>=4 (>=5 if sur)	1
4,980	81.96594	0	female	0	22	725	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	under $11k	0	55,711	34,053.3125	38,240	29	white	27.699219	35	0.646973	0.546997	2	0	0	no	0.75	0.6	no dnr	22	86	10.798828	75	24	36.09375	195.21875	null	null	0.599976	139	7.289062	126	8	null	null	1	null	1
4,981	55.55899	0	female	0	6	726	CHF	COPD/CHF/Cirrhosis	5	16	>$50k	0	4,390	3,090.0312	3,410	9	white	18.398438	40	0.898926	0.830933	1	1	0	no	null	null	no dnr	6	43	11.599609	140	25	38.19531	119.98438	1.699951	6.399414	2.799805	145	7.389648	117	60	1,460	1	null	no(M2 and SIP pres)	1.166748
4,982	72.43799	0	male	0	10	726	Colon Cancer	Cancer	1	16	null	0	29,470	16,680.2812	16,380	31.5	white	45.398438	39	0.109985	0.004	1	0	0	metastatic	0.85	0.75	no dnr	10	78	36.09375	75	8	36.19531	286.625	2.5	0.599976	1.899902	149	7.439453	293	54	2,265	0	null	no(M2 and SIP pres)	0.494751
4,983	71.62195	1	female	0	31	74	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	null	null	null	13	white	17.398438	31	0.861938	0.771973	1	0	0	no	0.9	0.9	dnr after sadm	5	125	18	45	12	36	356	null	0.5	2.699707	138	7.369141	80	36	2,965	4	2	adl>=4 (>=5 if sur)	2
4,984	62.25299	0	male	0	9	725	COPD	COPD/CHF/Cirrhosis	3	5	$11-$25k	0	8,922	5,818.3086	6,201	10.5	white	16.097656	13	0.908936	0.845947	1	0	0	no	0.6	0.5	no dnr	9	57	0.299988	115	24	35	226.65625	null	null	0.899902	133	7.5	385	23	1,000	0	null	no(M2 and SIP pres)	0.494751
4,985	73.47595	1	female	0	23	173	MOSF w/Malig	ARF/MOSF	2	null	null	0	173,420	106,988	115,884	42	white	41	60	0.119995	0.052994	22	1	0	yes	0.1	0.1	no dnr	23	97	23.398438	125	26	38.29688	120.40625	null	null	1.299805	134	7.319336	181	5	2,065	null	0	no(M2 and SIP pres)	0
4,986	21.092	0	male	0	17	724	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	85,249	null	null	33	white	21.5	23	0.927979	0.901978	1	0	0	no	null	null	no dnr	17	0	12.298828	0	40	34.89844	45	2.5	0.699951	1.199951	136	7.319336	134	67	1,130	null	null	no(M2 and SIP pres)	1.738525
4,987	73.96295	1	female	0	20	360	MOSF w/Malig	ARF/MOSF	1	12	under $11k	9	52,654	32,165.2656	29,805	24.333328	black	14.298828	42	0.737915	0.655884	5	0	0	metastatic	0.1	0.5	dnr after sadm	2	138	24.199219	155	36	36.5	152.5	1.099854	1.5	2.299805	131	7.489258	123	30	638	null	3	SIP>=30	3
4,988	85.04297	1	male	0	22	517	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$11-$25k	0	45,706	27,916.375	28,557	19.333328	white	24.5	37	0.677979	0.583984	4	0	0	no	0.4	0.4	no dnr	22	75	10.5	54	16	36.59375	null	3.299805	0.399963	0.899902	139	null	74	15	null	null	4	SIP>=30	4
4,989	35.32397	0	female	0	25	723	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	44	109,937	64,685.5938	64,654	29	white	34.09375	55	0.501953	0.383972	11	0	0	no	0.6	0.6	no dnr	25	102	9.199219	125	22	36.39844	236.65625	null	null	1.099854	135	7.449219	89	13	3,725	null	null	null	2.575195
4,990	67.75397	1	female	0	6	42	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	5,817	4,031.8711	4,050	17	black	22.796875	27	0.819946	0.706909	1	0	0	no	null	null	no dnr	6	53	12.5	105	36	38.5	223.3125	null	null	1.399902	138	7.459961	269	28	2,275	3	3	<2 mo. follow-up	3
4,991	61.728	1	male	1	11	11	Coma	Coma	0	null	null	61	40,375	22,013.4062	23,827	31.5	white	24	36	0.41095	0.336975	2	0	0	no	0	0	dnr after sadm	8	58	3	35	30	34.89844	395.1875	2.599609	1.299805	2.099609	126	7.539062	705	46	3,820	null	null	<2 mo. follow-up	2.580566
4,992	60.435	0	male	0	18	721	ARF/MOSF w/Sepsis	ARF/MOSF	1	6	under $11k	41	31,813	19,738.3906	22,031	19.333328	white	18.898438	16	0.766968	0.691895	3	0	0	no	0.8	0.75	no dnr	18	110	10.298828	120	40	38.69531	152.5	null	null	0.5	139	7.489258	189	25	2,805	null	1	adl>=4 (>=5 if sur)	1
4,993	63.72098	1	male	0	19	193	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	9	56,207	33,346.6562	32,873	17.666656	white	35	44	0.482971	0.36499	6	0	0	no	0.4	0.3	no dnr	19	60	11.798828	120	30	35.59375	172.5	null	21.796875	8.898438	139	7.369141	168	83	9	0	5	no(M2 and SIP pres)	5
4,994	72.79095	0	female	0	13	721	CHF	COPD/CHF/Cirrhosis	3	7	$11-$25k	0	null	19,391.375	20,858	18	white	21.699219	26	0.815918	0.701904	1	1	0	no	null	null	no dnr	13	22	29.699219	0	0	37.59375	478	null	null	3.599609	126	7.229492	536	39	64	0	0	no(M2 and SIP pres)	0
4,995	25.95499	0	female	0	13	720	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	>$50k	0	null	null	null	15	white	20.597656	24	0.910889	0.878906	5	0	0	no	0.9	0.9	no dnr	13	58	9.298828	80	35	38.09375	243.3125	null	null	2.699707	143	7.5	108	111	1,785	0	0	no(M2 and SIP pres)	0
4,996	46.146	0	female	0	31	720	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	55	116,527	66,050.1875	67,149	39.5	white	30.199219	38	0.539917	0.425964	3	0	0	no	0.5	0.4	no dnr	31	52	1.099854	135	38	38.59375	44	null	22	4.5	150	7.129883	87	143	15	null	0	no(M2 and SIP pres)	0
4,997	65.37396	1	male	0	13	57	CHF	COPD/CHF/Cirrhosis	4	null	null	9	null	15,356.0469	13,818	23.5	white	20	28	0.843994	0.74292	1	1	0	no	null	null	no dnr	13	158	12.5	105	12	38.29688	356	2.899902	null	7.599609	138	7.349609	312	61	450	null	null	<2 mo. follow-up	3.125488
4,998	54.08899	0	male	0	7	718	Lung Cancer	Cancer	1	12	under $11k	0	null	7,479.207	7,614	12.5	black	22.398438	25	0.616943	0.302979	1	0	0	metastatic	null	null	no dnr	7	72	5.899414	75	16	36.5	null	null	0.399963	0.699951	143	null	77	13	1,475	null	0	no(M2 and SIP pres)	0
4,999	20.31799	0	female	0	16	719	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$11-$25k	0	70,709	39,993.9062	35,131	32.333313	white	27.398438	32	0.858887	0.810913	1	0	0	yes	0.5	0.5	no dnr	16	115	11.298828	75	27	33.89844	263.3125	null	0.699951	1.599854	148	7.399414	327	42	1,255	null	0	no(M2 and SIP pres)	0
5,000	60.82098	0	male	0	10	718	Coma	Coma	3	7	under $11k	0	null	25,320.9062	30,608	31.5	black	22	22	0.675903	0.619995	2	0	0	yes	0.8	0.75	no dnr	10	62	7.599609	145	10	39.09375	175	2.5	4	2	147	7.509766	149	77	1,520	null	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.